Home / Compliance actions / 108171

FDA Warning Letter — Jazz Pharmaceuticals, Inc

Case 108171 — FEI 3005615655

The FDA took a Warning Letter action against Jazz Pharmaceuticals, Inc on July 6, 2010 (Palo Alto, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Jazz Pharmaceuticals, Inc
Date
July 6, 2010
Fiscal Year
2010
Product Type
Drugs
Center
CDER
Location
Palo Alto, CA (United States)

Facility

Recent inspections

  • 1094205 (VAI Mon Jun 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 978492 (NAI Wed Jul 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 979392 (VAI Wed Jan 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 876999 (VAI Fri Apr 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 780816 (VAI Wed May 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other compliance actions

FDA data resources